2、证监会最新数据显示，截至7月底，合格境外投资者（QFII）数量已达900家，今年以来新增40家。证监会表示，后续还将出台更多优化合格境外投资者 制度的改革举措，有力推进资本市场高水平制度型开放。市场人士分析，从证监会近日召开的"十五五"资本市场规划专家学者座谈会透露的政策信号看，新 一轮资本市场改革开放有望加快推进。进一步提高跨境投融资便利性，进一步优化准入管理、投资运作等举措值得期待，外资机构有望向中国市场投出更 多"信任票"。 热点聚焦 1、近日，财政部与中国人民银行联合工作组召开第二次组长会议。会议就金融市场运行、政府债券发行管理、央行国债买卖操作和完善离岸人民币国债发 行机制等议题进行了深入研讨。下一步，要持续推动我国债券市场平稳健康发展，共同保障财政政策、货币政策更好落地见效。 热门中概股多数走低，纳斯达克中国金龙指数跌0.19%。再鼎医药跌6.12%，蔚来跌3.95%，小鹏汽车跌2.6%。 港股方面，三大指数周三集体收跌。截至收盘，恒生指数跌0.60%，科技指数跌0.78%，国企指数跌0.64%。 从市场表现来看，创新药、黄金、半导体股走强，而券商、银行股走弱。 公司要闻 3、高盛的一位高管最 ...

Core Viewpoint - Goldman Sachs reports that the Hong Kong Stock Exchange (HKEX) is taking steps towards simplifying its platform, enhancing capital efficiency for market participants, and aligning with international standards through the recent reduction of trading and settlement fees and the expansion of derivative product holding limits by the Securities and Futures Commission [1] Group 1: Revenue and Earnings Forecasts - Goldman Sachs has revised down its yield forecasts from Hong Kong's margin balances for HKEX to 1.97%, 1.39%, and 1.42% for this year, next year, and 2027 respectively [1] - The daily average sales volume for HKEX is projected to be HKD 249 billion, HKD 275 billion, and HKD 299 billion for the respective years [1] Group 2: Earnings Per Share and Target Price - The earnings per share forecasts for HKEX have been increased by 2%, 3%, and 4% for this year, next year, and 2027 respectively [1] - The target price for HKEX has been raised from HKD 509 to HKD 524, maintaining a "Buy" rating [1]

Core Viewpoint - The AI Fund West China Li De Hong Kong Stock Connect New Opportunities Mixed A (008861) reported a profit of 2.89 million yuan for the first half of 2025, with a weighted average profit per fund share of 0.1 yuan, and a net asset value growth rate of 18.93% during the reporting period [2]. Fund Performance - As of September 3, the fund's unit net value was 0.684 yuan, with a three-month return of 15.15%, a six-month return of 15.00%, a one-year return of 37.43%, and a three-year return of -9.60% [5]. - The fund's three-year Sharpe ratio was -0.0515, ranking 534 out of 875 comparable funds [27]. - The maximum drawdown over the past three years was 50.65%, with the largest single-quarter drawdown occurring in Q1 2022 at 28.84% [29]. Fund Holdings and Valuation - As of June 30, 2025, the fund's weighted average price-to-earnings (P/E) ratio was approximately 19.75 times, compared to the peer average of 15.75 times; the weighted average price-to-book (P/B) ratio was about 1.39 times, while the peer average was 2.52 times; and the weighted average price-to-sales (P/S) ratio was around 1.2 times, against a peer average of 2.16 times [11]. - The fund's weighted revenue growth rate for the first half of 2025 was 0.04%, and the weighted net profit growth rate was 0.49% [19]. Fund Composition - As of June 30, 2025, the fund had a total of 1,610 holders, with a total of 28.61 million shares held. Management employees held 1.61 million shares (5.63%), institutions held 15.75%, and individual investors accounted for 84.25% [36]. - The fund's top ten holdings included Tencent Holdings, Hong Kong Exchanges and Clearing, Alibaba-W, Kingdee International, China Mobile, HSBC Holdings, Xpeng Motors-W, Sanofi, AIA Group, and BeiGene [42]. Market Outlook - The fund management anticipates that the Hong Kong stock market will benefit from three favorable factors: the influx of innovative companies, continuous capital inflow from the mainland, and an increasing proportion of quality stocks in the Hong Kong market, which may attract foreign investment [2].

Group 1: Market Overview - The Hong Kong stock market continues to experience fluctuations, with the Hang Seng Index closing at 25,343.43, down 153 points or 0.6%, after a day of volatility [3] - The trading volume decreased to below 30 billion HKD, indicating reduced market activity [3] Group 2: Macro & Industry Dynamics - The sustainable debt market in Hong Kong is projected to grow steadily, with an estimated issuance of 34.3 billion USD in the first half of 2025, representing a 15% year-on-year increase [6] - The total issuance of green and sustainable debt in Hong Kong is expected to reach 84.4 billion USD in 2024, a significant 61% increase from the previous year [6] - Goldman Sachs forecasts a substantial increase in global merger and acquisition (M&A) activity, predicting a total deal volume of approximately 3.1 trillion USD in 2025, rising to 3.9 trillion USD in 2026 [8] Group 3: Company News - WuXi AppTec plans to raise 2.731 billion HKD through a share placement at a price of 58.85 HKD per share, with approximately 90% of the proceeds allocated to expanding service capacity and production capabilities [10] - Zijin Mining International is expected to raise at least 3 billion USD (approximately 23.4 billion HKD) in its Hong Kong listing, which is 50% higher than the initial estimate [11] - Henderson Land Development's CFO indicated that residential property prices in Hong Kong are nearing a bottom, with expectations of increased demand due to immigration [12]

Group 1 - The top three stocks with the highest short-selling ratios are China Resources Beer (100.00%), Lenovo Group (100.00%), and Anta Sports (100.00%) [1][2] - The top three stocks with the highest short-selling amounts are Alibaba (2.283 billion), Tencent Holdings (1.289 billion), and Xiaomi Group (1.113 billion) [1][2] - The top three stocks with the highest deviation values are China Resources Beer (50.97%), Lenovo Group (46.84%), and Tencent Holdings (44.51%) [1][2] Group 2 - The top ten short-selling ratio rankings include China Resources Beer, Lenovo Group, and Anta Sports, all at 100.00% [2] - The top ten short-selling amounts show Alibaba leading with 22.83 billion, followed by Tencent Holdings and Xiaomi Group [2] - The top ten deviation values highlight China Resources Beer and Lenovo Group with significant deviations from their average short-selling ratios [2]

Group 1 - Zhang Kun expressed that the pessimistic expectations for domestic demand are worth reconsidering, indicating a potential shift in consumer sentiment [1][7][8] - The E Fund Blue Chip Select Fund has optimized its holdings in technology and consumer sectors, increasing positions in consumer stocks and adding several information technology stocks [1][2] - The fund's stock position was slightly tightened, with the stock holding ratio decreasing from 94.14% to 92.63%, marking the lowest level in nearly three years [2] Group 2 - The top ten heavy stocks now account for 83.84% of the fund's net value, the highest in the past ten quarters, while the "invisible heavy stocks" have significantly reduced from 18.05% to 9.22% [2] - New additions to the fund's holdings include stocks like Beike-W and Chao Yan Technology, which have not been part of the portfolio in the last three years [3][4] - The fund has reduced its holdings in Meituan-W and Hong Kong Exchanges, with Meituan's shares decreasing by 46.43% over the last six months [3][6] Group 3 - Guo Lan has increased her focus on innovative drugs, with her funds showing significant positive returns, particularly in the medical sector [5][7] - The largest fund managed by Guo Lan holds 142 stocks, an increase of 28 from the previous year, with a turnover rate of 61.3% [5] - The top invisible heavy stocks in Guo Lan's portfolio include long-term holdings like Aier Eye Hospital and Mindray Medical, which have seen significant reductions in their positions [6][7] Group 4 - Guo Lan's investment strategy emphasizes innovative drugs and medical devices, predicting that innovation and consumer recovery will drive growth in the pharmaceutical sector [7][8] - The medical device sector is expected to continue its recovery, benefiting from increased health awareness and stable economic recovery [8] - Guo Lan maintains a long-term value investment framework, focusing on core areas such as innovative drugs and consumer healthcare [8]

Group 1 - The Hang Seng Index successfully maintained above the 25,000-point mark, with a strong inflow of southbound funds amounting to HKD 5.508 billion on September 3, 2023 [1] - Year-to-date net inflow of southbound funds has surpassed HKD 1 trillion, reaching approximately HKD 1,005.729 billion [1] - Southbound funds have become a key driver for enhancing liquidity in the Hong Kong stock market, with average daily trading volume in the first half of 2025 reaching HKD 111 billion, nearly three times that of the first half of 2024 [2] Group 2 - Southbound funds show a clear investment preference for high dividend, low valuation, and high growth sectors, with 81 stocks having over 20% ownership by southbound funds, primarily in healthcare, finance, industrial, and information technology [2] - The shift in southbound fund holdings from technology in Q1 to new consumption in Q2, and recently to healthcare and finance, indicates an increase in strategic allocation by mainland investors in the Hong Kong stock market [3] - The Hong Kong market features scarce high-quality assets, attracting more long-term investments from southbound funds, with 13 out of 59 newly listed stocks this year already included in the southbound trading scheme, focusing on popular sectors like consumption, technology, and pharmaceuticals [3]

Investment Rating - The report maintains a "Buy" rating for the non-bank financial sector [2] Core Insights - The report highlights a "slow bull" new cycle, indicating a revaluation of the sector with significant growth in insurance premiums and profits for listed insurance companies in 2025 [7] - The insurance sector is experiencing rapid growth in bank insurance, improved cost structures, and increased allocation to equity assets, reflecting a trend of "deposit migration" and rising industry concentration [7] - Brokerage firms continue to show strong performance, with a notable recovery in investment banking activities and a significant increase in net profits [7] - Financial technology firms are seeing strong revenue elasticity in C-end businesses, while B-end businesses face challenges due to declining downstream demand [7] - The report recommends focusing on companies with strong long-term profitability potential and suggests long-term holdings in leading and high-dividend stocks within the industry [7] Summary by Sections Insurance: Gradual Validation of ROE Revaluation - The 2025 interim report for listed insurance companies shows significant growth in value and premiums, with a focus on bank insurance growth and improved cost structures [12] - The new business value (NBV) increased by 31% year-on-year, and the net investment yield decreased slightly [13] - The allocation to equity assets has increased, with a notable rise in stock and fund exposure [12][13] Brokerage: Stability of Leading Firms' Profitability - In the first half of 2025, brokerage firms achieved a total revenue of 2,518.94 billion and a net profit of 1,036.05 billion, representing year-on-year increases of 11.3% and 65.6%, respectively [41] - The brokerage business continues to show strong growth, particularly in proprietary trading and brokerage services [41] - The average return on equity (ROE) for the sector increased to 3.5%, with leading firms showing significantly higher ROE [47] Financial Technology: Strong Elasticity in C-end Business - C-end business revenues are driven by increased trading demand, leading to improved profit margins, while B-end businesses remain under pressure [7] - The competitive landscape among large platforms remains stable, with revenue primarily driven by trading-related services [7] Investment Recommendations - The report emphasizes the shift in industry valuation from short-term trading risks to long-term profitability potential, recommending companies with strong earnings stability and growth potential [7] - Specific stock recommendations include New China Life Insurance, China Life, and China Pacific Insurance for the insurance sector, and Jiufang Zhitu, Tonghuashun, and CITIC Securities for the brokerage and financial IT sectors [7]

Group 1: Market Overview and Fund Manager Insights - Long-term institutional investors are revealing their holdings as the A-share market experiences fluctuations, with notable adjustments made by prominent fund managers like Zhang Kun and Ge Lan [1][12] - Zhang Kun expresses skepticism about the prevailing pessimistic expectations regarding domestic demand, suggesting that consumer confidence will eventually recover as market conditions improve [12][13] - Ge Lan focuses on the pharmaceutical sector, particularly innovative drugs and medical devices, indicating that these areas will drive growth in the industry [14] Group 2: Fund Holdings and Adjustments - Zhang Kun's management of the E Fund Blue Chip Select has seen a slight reduction in stock positions, with the fund's stock holding ratio decreasing from 94.14% to 92.63%, marking a three-year low [2] - The top ten holdings of the E Fund Blue Chip Select now account for 83.84% of the fund's net value, the highest in the past ten quarters, while the "invisible heavyweights" (ranked 11-20) have significantly decreased in value [2][3] - New additions to the E Fund Blue Chip Select include several technology and consumer stocks, while previous holdings like New秀丽 and 迈瑞医疗 have been removed [3][6] Group 3: Performance of Key Stocks - Among the "invisible heavyweights," 分众传媒 has seen an increase in holdings, while 美团-W has been reduced by 46.43%, dropping to the 12th position [3][4] - Ge Lan's funds have also shown similar trends, with stocks like 爱尔眼科 and 迈瑞医疗 experiencing significant reductions in holdings [7][8] - The performance of key stocks in Ge Lan's portfolio has supported fund value increases, with some stocks like 药明康德 and 华海药业 seeing substantial gains [11] Group 4: Future Outlook and Investment Strategies - Zhang Kun believes that the long-term potential for consumer spending will improve as economic conditions stabilize, emphasizing the importance of consumer income expectations [12][13] - Ge Lan anticipates that the pharmaceutical industry will continue to grow driven by innovation and recovery in consumer demand, with a focus on maintaining a long-term value investment strategy [14]

Core Points - The Hong Kong Stock Exchange announced that the exchange rate deduction rates for RMB to HKD and RMB to USD will remain at 2.6% after market close on September 5, 2025 [1] - The deduction rate for USD to HKD will be revised from 0.7% to 1% effective September 5, 2025 [1] - The deduction rate for using HKD or USD as collateral for early use of frozen securities under the China Connect will remain at 3.7% starting September 5, 2025 [1]